Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Kraig"), the leading developer of advanced spider silk based fibers, today announced plans to add key personnel, in order to support its production growth strategy and expand its ability to service potential clients as Kraig grows.

Kraig is looking to add two talented and experienced individuals to its team, to help with a wide array of responsibilities, ranging from operations to market development.

The fundamental considerations include a balanced mix of qualifications, experience and reputation.

"We're looking for key individuals, to work as part of a cooperative team to accelerate the Company's growth in 2013 and beyond," stated Company CEO and founder, Kim K Thompson. "In addition to improving organizational effectiveness, I welcome the addition of valuable perspective and insight that these key hires may add to our organization. Frankly, as we transition from being a research and development company to the commercialization of new recombinant fibers, we need to add more hands on deck to take on the increased responsibilities. I am thrilled to be adding to our executive team to help guide our product development, sales and marketing, and technological efforts."

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT: Ben Hansel, Hansel Capital, LLC.
         (720) 288-8495
         ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Kraig Biocraft Laborator... (QB) Charts.
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Kraig Biocraft Laborator... (QB) Charts.